TipRanks
Advertisement
Advertisement

ACHV Stock Latest News

ACHV: Buy Rating Reaffirmed as Strong ORCA-OL Efficacy and Safety Data Support Unchanged $13 Price Target
RatingsACHV: Buy Rating Reaffirmed as Strong ORCA-OL Efficacy and Safety Data Support Unchanged $13 Price Target
1d ago
ACHV
Achieve Life Sciences presents positive 52-week cytisinicline results
PremiumThe Fly
Achieve Life Sciences presents positive 52-week cytisinicline results
2d ago
ACHV
Achieve Life Sciences Appoints Benjamin Halladay as CFO
PremiumCompany Announcements
Achieve Life Sciences Appoints Benjamin Halladay as CFO
22d ago
8K
ACHV
Achieve Life Sciences appoints Halladay as Chief Financial Officer
PremiumThe Fly
Achieve Life Sciences appoints Halladay as Chief Financial Officer
22d ago
ACHV
Morning Movers: Boeing jumps after landing $20B Navy contract
PremiumThe Fly
Morning Movers: Boeing jumps after landing $20B Navy contract
23d ago
BA
CAG
Achieve Life Sciences initiated with a Buy at Stifel
PremiumThe FlyAchieve Life Sciences initiated with a Buy at Stifel
24d ago
ACHV
Achieve Life Sciences price target lowered to $18 from $20 at Raymond James
Premium
The Fly
Achieve Life Sciences price target lowered to $18 from $20 at Raymond James
2M ago
ACHV
Achieve Life Sciences initiated with an Overweight at Morgan Stanley
Premium
The Fly
Achieve Life Sciences initiated with an Overweight at Morgan Stanley
2M ago
ACHV
Five Below, Achieve, Tronox, Brightstar, Inovio Trending
PremiumWeekend Updates
Five Below, Achieve, Tronox, Brightstar, Inovio Trending
2M ago
INO
ACHV
Achieve Life Sciences Launches $150M ATM Equity Program
PremiumCompany Announcements
Achieve Life Sciences Launches $150M ATM Equity Program
2M ago
8K
ACHV
Achieve Maintained at Buy as Cytisinicline Resubmission and Strong Cash Runway Support Unchanged $13 Price Target
PremiumRatings
Achieve Maintained at Buy as Cytisinicline Resubmission and Strong Cash Runway Support Unchanged $13 Price Target
2M ago
ACHV
Analyst Maintains Buy Rating on Achieve Life Sciences with Unchanged $17 Price Target, Backed by Cytisinicline Launch Readiness and FDA Pathway Clarity
PremiumRatings
Analyst Maintains Buy Rating on Achieve Life Sciences with Unchanged $17 Price Target, Backed by Cytisinicline Launch Readiness and FDA Pathway Clarity
2M ago
ACHV
Achieve Maintains Strong Cash Position and Clear FDA Path; Brandon Folkes Reiterates Buy Rating and Unchanged $12 Price Target
PremiumRatingsAchieve Maintains Strong Cash Position and Clear FDA Path; Brandon Folkes Reiterates Buy Rating and Unchanged $12 Price Target
2M ago
ACHV
Achieve Life Sciences reports Q2 EPS (80c), consensus (16c)
Premium
The Fly
Achieve Life Sciences reports Q2 EPS (80c), consensus (16c)
2M ago
ACHV
ACHV, HUM, APTV, FIS, ADM Trending With Analysts
Premium
Weekend Updates
ACHV, HUM, APTV, FIS, ADM Trending With Analysts
3M ago
ADM
FIS
Achieve Life Sciences initiated with an Outperform at LifeSci Capital
PremiumThe Fly
Achieve Life Sciences initiated with an Outperform at LifeSci Capital
3M ago
ACHV
ACHV Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
ACHV Upcoming Earnings Report: What to Expect?
3M ago
ACHV
Achieve Life Sciences Expands Authorized Shares After Stockholder Vote
PremiumCompany Announcements
Achieve Life Sciences Expands Authorized Shares After Stockholder Vote
4M ago
8K
ACHV
Achieve Life Sciences added to Russell 2000 Index
PremiumThe Fly
Achieve Life Sciences added to Russell 2000 Index
4M ago
ACHV
Achieve Life Sciences resumed with a Strong Buy at Raymond James
PremiumThe FlyAchieve Life Sciences resumed with a Strong Buy at Raymond James
4M ago
ACHV
Achieve Life Sciences CRL from FDA cites deficiencies at manufacturing facility
Premium
The Fly
Achieve Life Sciences CRL from FDA cites deficiencies at manufacturing facility
4M ago
ACHV
Achieve Life Sciences Adds Two Independent Board Directors
Premium
Company Announcements
Achieve Life Sciences Adds Two Independent Board Directors
5M ago
8K
ACHV

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >